167 related articles for article (PubMed ID: 20162337)
21. Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis.
Xu T; Chen J; Lu Y; Wolff JE
BMC Cancer; 2010 Jun; 10():252. PubMed ID: 20525214
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE)
Mokkarala M; Noda C; Malone C; Ramaswamy R; Akinwande O
Anticancer Res; 2019 Jun; 39(6):3071-3077. PubMed ID: 31177151
[TBL] [Abstract][Full Text] [Related]
23. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
[TBL] [Abstract][Full Text] [Related]
24. Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma.
Urbano J; Echevarria-Uraga JJ; Ciampi-Dopazo JJ; Sánchez-Corral JA; Cobos Alonso J; Anton-Ladislao A; Peña-Baranda B; Nacarino-Mejias V; González-Costero R; Muñoz Ruiz-Canela JJ; Pérez-Cuesta J; Lanciego C; de Gregorio MA
Eur J Radiol; 2020 May; 126():108966. PubMed ID: 32278280
[TBL] [Abstract][Full Text] [Related]
25. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
Richardson AJ; Laurence JM; Lam VW
J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
[TBL] [Abstract][Full Text] [Related]
26. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
Santisteban M; Buckner JC; Reid JM; Wu W; Scheithauer BW; Ames MM; Felten SJ; Nikcevich DA; Wiesenfeld M; Jaeckle KA; Galanis E;
J Neurooncol; 2009 Apr; 92(2):165-75. PubMed ID: 19066728
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model.
Aoki H; Kakinuma K; Morita K; Kato M; Uzuka T; Igor G; Takahashi H; Tanaka R
Int J Hyperthermia; 2004 Sep; 20(6):595-605. PubMed ID: 15370816
[TBL] [Abstract][Full Text] [Related]
30. Canine spontaneous glioma: a translational model system for convection-enhanced delivery.
Dickinson PJ; LeCouteur RA; Higgins RJ; Bringas JR; Larson RF; Yamashita Y; Krauze MT; Forsayeth J; Noble CO; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
Neuro Oncol; 2010 Sep; 12(9):928-40. PubMed ID: 20488958
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: a comparative analysis using rodent models of gliomas.
Mima T; Mostafa MG; Mori K
Neurol Res; 2000 Dec; 22(8):819-24. PubMed ID: 11149245
[TBL] [Abstract][Full Text] [Related]
32. Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report.
Kuhn JG
Oncology (Williston Park); 2002 Aug; 16(8 Suppl 7):33-40. PubMed ID: 12199631
[TBL] [Abstract][Full Text] [Related]
33. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
Emerich DF; Winn SR; Bartus RT
Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
[TBL] [Abstract][Full Text] [Related]
34. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
[TBL] [Abstract][Full Text] [Related]
35. Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety.
Zhang ZS; Li HZ; Ma C; Xiao YD
BMC Cancer; 2019 Nov; 19(1):1162. PubMed ID: 31783814
[TBL] [Abstract][Full Text] [Related]
36. Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer.
Liu T; Wang C; Gu X; Gong H; Cheng L; Shi X; Feng L; Sun B; Liu Z
Adv Mater; 2014 Jun; 26(21):3433-40. PubMed ID: 24677423
[TBL] [Abstract][Full Text] [Related]
37. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts.
Krauze MT; Noble CO; Kawaguchi T; Drummond D; Kirpotin DB; Yamashita Y; Kullberg E; Forsayeth J; Park JW; Bankiewicz KS
Neuro Oncol; 2007 Oct; 9(4):393-403. PubMed ID: 17652269
[TBL] [Abstract][Full Text] [Related]
38. Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads.
Yagublu V; Caliskan N; Lewis AL; Jesenofsky R; Gasimova L; Löhr JM; Keese M
Pancreatology; 2013; 13(1):79-87. PubMed ID: 23395574
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study.
Loghin ME; Prados MD; Wen P; Junck L; Lieberman F; Fine H; Fink KL; Metha M; Kuhn J; Lamborn K; Chang SM; Cloughesy T; DeAngelis LM; Robins IH; Aldape KD; Yung WK
Clin Cancer Res; 2007 Dec; 13(23):7133-8. PubMed ID: 18056194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]